We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.02B
AUM Growth
+$434M
Cap. Flow
+$190M
Cap. Flow %
6.3%
Top 10 Hldgs %
45.02%
Holding
338
New
35
Increased
173
Reduced
106
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
251
DELISTED
Amicus Therapeutics
FOLD
$346K 0.01%
24,368
-283
-1% -$3.21K
HIPS icon
252
GraniteShares HIPS US High Income ETF
HIPS
$112M
$340K 0.01%
27,231
+717
+3% +$8.6K
GEHC icon
253
GE HealthCare
GEHC
$31.2B
$338K 0.01%
4,372
+38
+0.9% +$2.66K
BIV icon
254
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$334K 0.01%
4,377
-4,115
-48% -$301K
IWP icon
255
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
$333K 0.01%
3,186
+216
+7% +$20.5K
FE icon
256
FirstEnergy
FE
$28.2B
$330K 0.01%
9,000
-2
-0% -$72
CNI icon
257
Canadian National Railway
CNI
$76.6B
$330K 0.01%
2,623
+8
+0.3% +$906
SPYV icon
258
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.3B
$326K 0.01%
7,002
-986
-12% -$42.5K
LNG icon
259
Cheniere Energy
LNG
$54.4B
$316K 0.01%
1,853
FTSL icon
260
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$311K 0.01%
6,753
+103
+2% +$4.72K
IR icon
261
Ingersoll Rand
IR
$33.7B
$290K 0.01%
3,755
-302
-7% -$20.6K
IWY icon
262
iShares Russell Top 200 Growth ETF
IWY
$16B
$289K 0.01%
1,649
IOVA icon
263
Iovance Biotherapeutics
IOVA
$1.89B
$285K 0.01%
34,998
+20,227
+137% +$106K
EPD icon
264
Enterprise Products Partners
EPD
$81.6B
$270K 0.01%
+10,258
New +$273K
DELL icon
265
Dell
DELL
$271B
$270K 0.01%
3,529
+38
+1% +$2.69K
ODFL icon
266
Old Dominion Freight Line
ODFL
$44.4B
$270K 0.01%
+1,332
New +$264K
MCK icon
267
McKesson
MCK
$99.7B
$270K 0.01%
582
+2
+0.3% +$909
FBIN icon
268
Fortune Brands Innovations
FBIN
$6.1B
$268K 0.01%
3,516
+11
+0.3% +$724
ITA icon
269
iShares US Aerospace & Defense ETF
ITA
$14.3B
$267K 0.01%
2,111
-98
-4% -$11.3K
MTB icon
270
M&T Bank
MTB
$35.9B
$267K 0.01%
1,946
-7
-0.4% -$880
CSX icon
271
CSX Corp
CSX
$93B
$264K 0.01%
+7,620
New +$243K
LHX icon
272
L3Harris
LHX
$51.6B
$254K 0.01%
1,205
-12
-1% -$2.25K
MUB icon
273
iShares National Muni Bond ETF
MUB
$45.2B
$253K 0.01%
+2,338
New +$244K
ECBK icon
274
ECB Bancorp
ECBK
$181M
$251K 0.01%
20,000
+4,445
+29% +$50.2K
PSX icon
275
Phillips 66
PSX
$84.2B
$251K 0.01%
+1,882
New +$225K

Similar funds

Grimes & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Grimes & Company held 338 positions worth $3.02B, up 17% from $2.59B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $190M of net new capital in Q4 2023, opening 35 new positions and adding to 173 existing holdings. Its largest new stake was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $163M trimmed.

  • Grimes & Company's largest Q4 2023 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.
  • Grimes & Company added most to iShares Core MSCI Emerging Markets ETF in Q4 2023, an estimated $83M increase.
  • Grimes & Company's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $163M.
  • Grimes & Company fully exited State Street Financial Select Sector SPDR ETF in Q4 2023, selling an estimated $11.8M.
  • Grimes & Company's ten largest holdings make up 45% of its $3.02B portfolio in Q4 2023.
  • Grimes & Company opened 35 new positions and closed 7 in Q4 2023.
  • Grimes & Company's portfolio value rose 17% quarter-over-quarter to $3.02B.

Based on Grimes & Company's 13F filing for Q4 2023, filed 24 Jan 2024.